1,362
Participants
Start Date
March 31, 2006
Primary Completion Date
May 31, 2007
Study Completion Date
May 31, 2007
Lapaquistat acetate and simvastatin
Lapaquistat acetate 50 mg, tablets, orally, once daily and stable dose of simvastatin for up to 12 weeks.
Lapaquistat acetate and simvastatin
Lapaquistat acetate 100 mg, tablets, orally, once daily and stable dose of simvastatin for up to 12 weeks.
Simvastatin
Lapaquistat acetate placebo-matching tablets, orally, once daily and stable dose of simvastatin for up to 12 weeks.
Huntsville
Chandler
Scottsdale
Sierra Vista
Tucson
Beverly Hills
Long Beach
Sacramento
Spring Valley
Colorado Springs
Hialeah
Hollywood
Jacksonville
Jupiter
Kissimmee
Miami
Ocala
Pembroke Pines
Pinellas Park
Stuart
West Palm Beach
Arlington Heights
Chicago
Peoria
Indianapolis
Overland Park
Wichita
Louisville
Edina
St Louis
Las Vegas
Margate City
Raleigh
Statesville
Winston-Salem
Cincinnati
Columbus
Kettering
Bartlesville
Portland
Beaver
Downingtown
Tipton
Goose Creek
Jackson
Nashville
San Antonio
Norfolk
Richmond
Lakewood
Abbotsford
Coquitlam
Victoria
Winnipeg
Mount Pearl
St. John's
Cornwall
London
Oakville
Oshawa
Thornhill
Toronto
Cornwall
Mirabel
Saint-Lambert
Sherbrooke
Ste-Foy
Lead Sponsor
Takeda
INDUSTRY